560 papers
Microbiology explores the invisible world of tiny life forms that shape our health, environment, and even the air we breathe. From bacteria and viruses to fungi and parasites, this field investigates how these microscopic organisms interact with us and each other, driving everything from disease outbreaks to beneficial fermentation processes. Understanding them is crucial for developing new medicines, improving food safety, and combating global health challenges.
At Gist.Science, we make the latest discoveries in this dynamic field accessible to everyone. We process every new preprint uploaded to bioRxiv in this category, transforming dense academic findings into both clear, plain-language explanations and detailed technical summaries. This ensures that whether you are a student, a researcher, or simply curious, you can grasp the significance of cutting-edge science without getting lost in jargon.
Below are the most recent papers in microbiology, curated and summarized directly from the bioRxiv server to keep you at the forefront of discovery.
This paper introduces a high-resolution, multi-level Life Identification Number (LIN) barcoding system for *Neisseria meningitidis*, developed through whole-genome sequencing analysis of over 6,000 isolates to provide a precise nomenclature for tracking population diversity and enhancing public health surveillance.
Using two in vivo preclinical models, this study demonstrates that a single dose of tafenoquine offers superior transmission-blocking efficacy and more favorable pharmacokinetics beyond 24 hours compared to primaquine, suggesting its potential advantage as a malaria transmission intervention.
This study establishes the first genetic manipulation method for *Lactobacillus iners* by demonstrating its natural competence, which enables the use of exogenous DNA to successfully disrupt specific genes like *iny* and *comGA* for functional analysis of this prevalent vaginal bacterium.
This paper introduces a data-driven, neural network-based approach called SCiFI that reduces the complexity of diverse microbiomes into a few interpretable functional groups, enabling the construction of simple structure-function maps and the discovery of underlying molecular mechanisms through targeted experiments.
This study reveals that the transmembrane protein Tmn defends bacteria against phage infection by forming a decameric complex that, upon recognizing the phage RIIB protein, triggers Mg2+ export and ATP-driven plasmolysis to arrest viral replication while simultaneously activating synergistic secondary defence systems.
This study identifies Itr4, a novel inositol transceptor in *Cryptococcus neoformans* that uniquely regulates both inositol and glucose metabolism to control fungal virulence traits such as mating, capsule size, and blood-brain barrier penetration.
This study analyzes 450 *Pseudomonas aeruginosa* isolates from a cystic fibrosis patient's lung over 1.5 years to reveal that while the infection consists of distinct phylogenetic lineages with parallel adaptive mutations, these populations are not strictly compartmentalized by lung lobe but instead exhibit significant migration and microheterogeneity driven by within-host evolution.
This study demonstrates that combining interpretable interface mapping with generative AI design enables the creation of structure-guided peptides that mimic native interactions to disrupt the FtsQBL divisome complex, thereby inhibiting cell division and growth in *Escherichia coli*.
This study demonstrates that a modified Elek test, incorporating optimized antitoxin concentration, incubation temperature, and plate layout, significantly improves the in-vitro detection of diphtheria toxin in previously non-toxigenic isolates of *Corynebacterium diphtheriae*, *C. ulcerans*, and *C. ramonii*.
This study demonstrates that specific combinations of nasal commensal bacteria, particularly *Staphylococcus* species or synergistic mixes of *Corynebacterium* and *Dolosigranulum pigrum*, effectively inhibit methicillin-resistant *Staphylococcus aureus* (MRSA) regardless of antibiotic resistance profiles, supporting the potential of microbiota-based therapies to prevent colonization.